• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于抗体结合的荧光分析方法,用于快速定量人 Fabry 细胞中的神经节苷脂 GM3 水平。

An antibody binding-based fluorescent assay for the rapid quantification of globotriaosylceramide levels in human Fabry cells.

机构信息

School of Science, Monash University Malaysia, 47500, Subang Jaya, Selangor Darul Ehsan, Malaysia.

School of Science, Monash University Malaysia, 47500, Subang Jaya, Selangor Darul Ehsan, Malaysia.

出版信息

Anal Biochem. 2021 Sep 1;628:114287. doi: 10.1016/j.ab.2021.114287. Epub 2021 Jun 10.

DOI:10.1016/j.ab.2021.114287
PMID:34119486
Abstract

Fabry disease is caused by reduced α-GAL A activity and accumulation of globotriaosylceramide (Gb). Here, we describe a microplate Gb assay using fluorophore-tagged antibody and crude cellular lipid extracts. The assay is able to detect higher Gb concentrations in human Fabry cells compared to non-diseased cells. This result was verified by immunofluorescence staining that revealed large amounts of Gb deposits in Fabry cell lines, demonstrating the accuracy of this method. This assay may provide the basis for detecting Fabry disease by quantifying Gb deposits from human biological samples, for example, from urine and blood.

摘要

法布里病是由于α-GAL A 活性降低和糖鞘脂(Gb)积累引起的。在这里,我们描述了一种使用荧光标记抗体和粗细胞脂质提取物的微孔板 Gb 测定法。与非病变细胞相比,该测定法能够检测到更高浓度的人 Fabry 细胞中的 Gb。通过免疫荧光染色证实了这一结果,该染色显示 Fabry 细胞系中有大量的 Gb 沉积,证明了该方法的准确性。该测定法可通过定量人生物样品(例如尿液和血液)中的 Gb 沉积来为检测法布里病提供依据。

相似文献

1
An antibody binding-based fluorescent assay for the rapid quantification of globotriaosylceramide levels in human Fabry cells.一种基于抗体结合的荧光分析方法,用于快速定量人 Fabry 细胞中的神经节苷脂 GM3 水平。
Anal Biochem. 2021 Sep 1;628:114287. doi: 10.1016/j.ab.2021.114287. Epub 2021 Jun 10.
2
Determination of globotriaosylceramide in plasma and urine by mass spectrometry.采用质谱法测定血浆和尿液中的神经节苷脂 GM3
Clin Chem Lab Med. 2010 Feb;48(2):189-98. doi: 10.1515/CCLM.2010.048.
3
An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: utility for Fabry disease diagnosis and treatment monitoring.一种从尿沉渣中测定球三糖神经酰胺(Gb3)的简便灵敏方法:对法布里病诊断和治疗监测的效用
Clin Chim Acta. 2009 May;403(1-2):194-7. doi: 10.1016/j.cca.2009.02.016. Epub 2009 Mar 4.
4
Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients.法布里病患者结膜活检中球三糖神经酰胺沉积物的免疫荧光检测。
Clin Exp Ophthalmol. 2006 Sep-Oct;34(7):689-94. doi: 10.1111/j.1442-9071.2006.01318.x.
5
Is globotriaosylceramide a useful biomarker in Fabry disease?球三糖神经酰胺在法布里病中是一种有用的生物标志物吗?
Acta Paediatr Suppl. 2005 Mar;94(447):51-4; discussion 37-8. doi: 10.1111/j.1651-2227.2005.tb02112.x.
6
High-Risk Screening of Fabry Disease: Analysis of Fifteen Urinary Methylated and Non-Methylated Gb Isoforms Using Tandem Mass Spectrometry.法布里病的高危筛查:使用串联质谱法分析15种尿甲基化和非甲基化Gb异构体
Curr Protoc Hum Genet. 2016 Oct 11;91:17.24.1-17.24.11. doi: 10.1002/cphg.24.
7
Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease Patients.采用 LC-MS/MS 法对法布雷病患者尿液中的乳糖基神经酰胺、半乳糖基神经酰胺和Globotriaosylceramide 进行分离和分析。
Anal Chem. 2017 Dec 19;89(24):13382-13390. doi: 10.1021/acs.analchem.7b03609. Epub 2017 Nov 27.
8
Analysis of Globotriaosylceramide (Gb) in Liquid Urine: A Straightforward Assay Using Tandem Mass Spectrometry.液相尿液中神经节苷脂Gb 的分析:一种使用串联质谱的简单方法。
Curr Protoc. 2024 Jun;4(6):e1087. doi: 10.1002/cpz1.1087.
9
A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients.一种基于基质辅助激光解吸电离飞行时间质谱的新型快速方法,用于测量法布里病患者尿中的球三糖神经酰胺。
J Am Soc Mass Spectrom. 2016 Apr;27(4):719-25. doi: 10.1007/s13361-015-1318-4. Epub 2016 Jan 21.
10
Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations before the occurrence of typical pathological changes in the endomyocardial biopsies of Fabry disease patients.在法布里病患者心肌活检中出现典型病理变化之前,鉴定溶酶体和溶酶体外糖鞘脂(Gb3)蓄积。
Genet Med. 2019 Jan;21(1):224-232. doi: 10.1038/s41436-018-0010-z. Epub 2018 Jun 6.